Company profile GMDA

Gamida Cell Ltd
gamida cell is a leader in cellular and immune therapeutics, committed to changing the treatment paradigm for patients with cancer and rare genetic diseases. we are building a broad pipeline based on our proprietary nam technology platform. our lead program, nicord, is in phase 3 development for allogeneic bone marrow transplantation and was granted breakthrough therapy designa...tion by the fda. Show More
Quarter analysis & expected interest

There is not enough data for Gamida Cell login to provide analysis

Correlation between past revenue and Gamida Cell login search interest

There is not enough data for Gamida Cell login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Gamida Cell omidubicel to provide analysis

Correlation between past revenue and Gamida Cell omidubicel search interest

There is not enough data for Gamida Cell omidubicel to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell omidubicel to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Gamida Cell GDA-201 to provide analysis

Correlation between past revenue and Gamida Cell GDA-201 search interest

There is not enough data for Gamida Cell GDA-201 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell GDA-201 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 14:33:46.

After 39 days of this quarter the interest is at 69.0. Based on that we can calculate that during remaining 52 days it will total up to 161.0.
Gamida Cell stock expected interest is significantly higher compared to previous quarter (+235.4%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201948
111
131.2% QoQ
21
-81.1% QoQ
89
323.8% QoQ
2020 76
58.3% YoY -14.6% QoQ
140
26.1% YoY 84.2% QoQ
52
147.6% YoY -62.9% QoQ
229
157.3% YoY 340.4% QoQ
2021 355
367.1% YoY 55.0% QoQ
152
8.6% YoY -57.2% QoQ
97
86.5% YoY -36.2% QoQ
146
-36.2% YoY 50.5% QoQ
2022 141
-60.3% YoY -3.4% QoQ
57
-62.5% YoY -59.6% QoQ
121
24.7% YoY 112.3% QoQ
57
-61.0% YoY -52.9% QoQ
2023 158
12.1% YoY 177.2% QoQ
174
205.3% YoY 10.1% QoQ
76
-37.2% YoY -56.3% QoQ
48
-15.8% YoY -36.8% QoQ
2024 69
-56.3% YoY 43.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Gamida Cell stock search interestLast update: February 09 2024 14:33:44.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 14:33:47.

The average 5 years interest of Gamida Cell stock was 9.26 per week.
The last year interest of Gamida Cell stock compared to the last 5 years has changed by -13.39%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 34.56%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Gamida Cell clinical trials to provide analysis

Correlation between past revenue and Gamida Cell clinical trials search interest

There is not enough data for Gamida Cell clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Gamida Cell blood cancers to provide analysis

Correlation between past revenue and Gamida Cell blood cancers search interest

There is not enough data for Gamida Cell blood cancers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell blood cancers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Gamida Cell severe aplastic anemia to provide analysis

Correlation between past revenue and Gamida Cell severe aplastic anemia search interest

There is not enough data for Gamida Cell severe aplastic anemia to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell severe aplastic anemia to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Gamida Cell biopharmaceutical company to provide analysis

Correlation between past revenue and Gamida Cell biopharmaceutical company search interest

There is not enough data for Gamida Cell biopharmaceutical company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell biopharmaceutical company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Gamida Cell Jerusalem to provide analysis

Correlation between past revenue and Gamida Cell Jerusalem search interest

There is not enough data for Gamida Cell Jerusalem to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell Jerusalem to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Gamida Cell cell therapies to provide analysis

Correlation between past revenue and Gamida Cell cell therapies search interest

There is not enough data for Gamida Cell cell therapies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Gamida Cell cell therapies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for GMDA
Earnings date: 2024-02-27 After close
Company name: Gamida Cell Ltd
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-12-08T00:00:00.000Z

US FDA
FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia

2025-05-12T11:30:00Z

GlobeNewswire
Purple Biotech Appoints Shai Lankry as Chief Financial Officer

2024-07-22T12:30:00Z

GlobeNewswire
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

2024-04-22T17:26:17-04:00

SEC
8-K Form - Current report, item 1.03 - Gamida Cell Ltd. (0001600847) (Filer)

2024-04-11T17:26:20-04:00

SEC
8-K/A Form - [Amend] Current report, items 8.01 and 9.01 - Gamida Cell Ltd. (0001600847) (Filer)

2024-04-08T11:30:00Z

GlobeNewswire
XORTX Welcomes New Member to the Board of Directors

2024-04-05T17:16:31-04:00

SEC
8-K/A Form - [Amend] Current report, items 8.01 and 9.01 - Gamida Cell Ltd. (0001600847) (Filer)

2024-04-01T17:49:42-04:00

SEC
SC 13G/A Form - [Amend] Statement of acquisition of beneficial ownership by individuals - Gamida Cell Ltd. (0001600847) (Subject)

2024-04-01T12:00:00Z

GlobeNewswire
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

2024-03-28T21:47:19-04:00

SEC
8-K/A Form - [Amend] Current report, items 3.01, 8.01, and 9.01 - Gamida Cell Ltd. (0001600847) (Filer)

2024-03-27T11:01:02-04:00

Earnings Call Transcripts
Gamida Cell Ltd. (GMDA) Q4 2023 Earnings Call Transcript

2024-03-27T07:35:28-04:00

SEC
10-K Form - Annual report [Section 13 and 15(d), not S-K Item 405] - Gamida Cell Ltd. (0001600847) (Filer)

2024-03-27T07:30:44-04:00

SEC
8-K Form - Current report, items 1.01, 2.02, 2.04, 2.05, 5.02, 8.01, and 9.01 - Gamida Cell Ltd. (0001600847) (Filer)

2024-03-27T11:00:00Z

GlobeNewswire
Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management

2024-03-27T11:00:00Z

GlobeNewswire
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update